Ebola: Is there a hope from treatment with cardiovascular drugs?

被引：22
|
作者：
Patane, Salvatore [1 ]
机构：
[1] Cardiol Osped San Vincenzo Taormina Me Azienda Sa, I-98039 Messina, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 177卷 / 02期
关键词：
Amiodarone; Doxazosin; Statin; Pentoxifylline; Propranolol; Verapamil; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; BACTERIAL-ENDOCARDITIS PROPHYLAXIS; HUMAN-IMMUNODEFICIENCY-VIRUS; ENDOTHELIAL GROWTH-FACTOR; ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; HEPATITIS-C VIRUS; SINE-QUA-NON; ATRIAL-FIBRILLATION; TISSUE FACTOR;
D O I：
10.1016/j.ijcard.2014.08.114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：524 / 526
页数：3
相关论文
共 50 条
  • [21] The P-Glycoprotein Transport System and Cardiovascular Drugs
    Wessler, Jeffrey D.
    Grip, Laura T.
    Mendell, Jeanne
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (25) : 2495 - 2502
  • [22] Cardiovascular Drugs Inducing QT Prolongation: Facts and Evidence
    Taira, Carlos A.
    Opezzo, Javier A. W.
    Mayer, Marcos A.
    Hocht, Christian
    CURRENT DRUG SAFETY, 2010, 5 (01) : 65 - 72
  • [23] Impact of Switching Treatment From Rosuvastatin to Atorvastatin on Rates of Cardiovascular Events
    Folse, Henry
    Sternhufvud, Catarina
    Schuetz, C. Andy
    Rengarajan, Badri
    Gandhi, Sanjay
    CLINICAL THERAPEUTICS, 2014, 36 (01) : 58 - 69
  • [24] Cardiovascular Risk Management and Hepatitis C: Combining Drugs
    Smolders, Elise J.
    ter Horst, Peter J. G.
    Wolters, Sharon
    Burger, David M.
    CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 565 - 592
  • [25] Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
    Gelosa, Paolo
    Castiglioni, Laura
    Camera, Marina
    Sironi, Luigi
    BIOCHEMICAL PHARMACOLOGY, 2020, 177
  • [26] Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
    Fuggle, N. R.
    Cooper, C.
    Harvey, N. C.
    Al-Daghri, N.
    Brandi, M. -L.
    Bruyere, O.
    Cano, A.
    Dennison, E. M.
    Diez-Perez, A.
    Kaufman, J. -M.
    Palacios, S.
    Prieto-Alhambra, D.
    Rozenberg, S.
    Thomas, T.
    Tremollieres, F.
    Rizzoli, R.
    Kanis, J. A.
    Reginster, J. Y.
    DRUGS, 2020, 80 (15) : 1537 - 1552
  • [27] Update on Statins: Hope for Osteoporotic Fracture Healing Treatment
    Ibrahim, Nurul 'Izzah
    Mohamed, Norazlina
    Shuid, Ahmad Nazrun
    CURRENT DRUG TARGETS, 2013, 14 (13) : 1524 - 1532
  • [28] Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis
    Um, Kevin J.
    McIntyre, William F.
    Mendoza, Pablo A.
    Ibrahim, Omar
    Nguyen, Stephanie T.
    Lin, Sabrina H.
    Duceppe, Emmanuelle
    Rochwerg, Bram
    Healey, Jeff S.
    Koziarz, Alex
    Lengyel, Alexandra P.
    Bhatnagar, Akash
    Amit, Guy
    Chu, Victor A.
    Whitlock, Richard P.
    Belley-Cote, Emilie P.
    EUROPACE, 2022, 24 (10): : 1548 - 1559
  • [29] Beyond Drugs and Ablation New Hope for Symptom Management in Patients With Paroxysmal Atrial Fibrillation?
    McCabe, Pamela J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (01) : 57 - 59
  • [30] Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
    Madelain, Vincent
    Thi Huyen Tram Nguyen
    Olivo, Anaelle
    de Lamballerie, Xavier
    Guedj, Jeremie
    Taburet, Anne-Marie
    Mentre, France
    CLINICAL PHARMACOKINETICS, 2016, 55 (08) : 907 - 923
12345